Completed NA INTERVENTIONAL NCT00350480

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

Treatment of Non-Gestational Acute Uterine BleedingComparing Oral Medroxyprogesterone Acetate and Monophasic Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol

Sponsor: Kaiser Permanente

Conditions Menorrhagia Uterine Hemorrhage

Interventions Combination Birth Control pills Provera

Updated 5 times since 2017 Last updated: Mar 10, 2015 Started: Apr 30, 2003 Completion: Jun 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00350480, this NA trial focuses on Menorrhagia and Uterine Hemorrhage and remains completed. Sponsored by Kaiser Permanente, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaiser Permanente

Data source: Kaiser Permanente

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States